Millennium II Materials Technology Fund

Venture Capital Active Israel
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$11.0M
total disclosed, rounds participated
Stages
—

Portfolio · 1

Enzymotec
Lipid-based Biofunctional Ingredients and Products
1 round $11.0M committed Latest: 2009-02

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Millennium II Materials Technology Fund's primary geographic focus?
Millennium II Materials Technology Fund is headquartered in Israel.
Which sectors does Millennium II Materials Technology Fund primarily invest in?
Millennium II Materials Technology Fund has a focus on the Health Tech & Life Sciences sector, with one investment round and one portfolio company in this area.
Can you name a notable portfolio company of Millennium II Materials Technology Fund?
A notable portfolio company of Millennium II Materials Technology Fund is Enzymotec, which specializes in lipid-based biofunctional ingredients and products.
Has Millennium II Materials Technology Fund had any exits?
Yes, Millennium II Materials Technology Fund had an exit in September 2013 with the IPO of Enzymotec on NASDAQ. Enzymotec had raised $63.5M in capital prior to its IPO.
What is the typical investment stage for Millennium II Materials Technology Fund?
Millennium II Materials Technology Fund has participated in B Round investments.
When did Millennium II Materials Technology Fund make its most recent investment?
Millennium II Materials Technology Fund's most recent recorded investment round was in February 2009.
What is the typical investment range for Millennium II Materials Technology Fund?
Millennium II Materials Technology Fund's investment range is between $11M and $11M.